News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,171 Results
Type
Article (13827)
Company Profile (101)
Press Release (252243)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88131)
Career Advice (465)
Deals (15355)
Drug Delivery (67)
Drug Development (36640)
Employer Resources (49)
FDA (6298)
Job Trends (6206)
News (150350)
Policy (14049)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (443)
Accelerated approval (2)
Adcomms (6)
Allergies (35)
Alliances (23263)
ALS (37)
Alzheimer's disease (393)
Antibody-drug conjugate (ADC) (42)
Approvals (6337)
Artificial intelligence (111)
Autoimmune disease (9)
Automation (4)
Bankruptcy (149)
Best Places to Work (4375)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (22)
Brain cancer (16)
Breast cancer (83)
Cancer (641)
Cardiovascular disease (72)
Career advice (408)
Career pathing (12)
CAR-T (22)
Cell therapy (89)
Cervical cancer (4)
Clinical research (30961)
Collaboration (353)
Compensation (155)
Complete response letters (17)
COVID-19 (762)
CRISPR (21)
C-suite (127)
Cystic fibrosis (37)
Data (664)
Denatured (15)
Depression (9)
Diabetes (83)
Diagnostics (1325)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (61)
Drug pricing (66)
Drug shortages (12)
Duchenne muscular dystrophy (37)
Earnings (32226)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (37622)
Executive appointments (397)
FDA (6731)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (220)
Gene editing (41)
Generative AI (9)
Gene therapy (101)
GLP-1 (350)
Government (1302)
Grass and pollen (3)
Guidances (17)
Healthcare (3582)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (35)
Indications (14)
Infectious disease (797)
Inflammatory bowel disease (56)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (48)
Interviews (59)
IPO (5886)
IRA (29)
Job creations (2051)
Job search strategy (373)
Kidney cancer (6)
Labor market (12)
Layoffs (180)
Leadership (3)
Legal (3434)
Liver cancer (19)
Lung cancer (87)
Lymphoma (57)
Machine learning (2)
Management (16)
Manufacturing (162)
MASH (33)
Medical device (1281)
Medtech (1283)
Mergers & acquisitions (9681)
Metabolic disorders (266)
Multiple sclerosis (21)
NASH (14)
Neurodegenerative disease (24)
Neuropsychiatric disorders (8)
Neuroscience (582)
NextGen: Class of 2025 (1587)
Non-profit (600)
Northern California (729)
Now hiring (8)
Obesity (152)
Opinion (120)
Ovarian cancer (22)
Pain (52)
Pancreatic cancer (15)
Parkinson's disease (47)
Partnered (7)
Patents (120)
Patient recruitment (29)
Peanut (10)
People (28986)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8066)
Phase II (13103)
Phase III (11748)
Pipeline (461)
Policy (72)
Postmarket research (1401)
Preclinical (3241)
Press Release (25)
Prostate cancer (48)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (170)
Real estate (2637)
Recruiting (17)
Regulatory (10140)
Reports (14)
Research institute (566)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (3)
RSV (8)
Schizophrenia (37)
Series A (39)
Series B (13)
Service/supplier (3)
Sickle cell disease (32)
Southern California (743)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1630)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (30)
The Weekly (30)
United States (7419)
Vaccines (157)
Venture capitalists (14)
Weight loss (100)
Women's health (8)
Worklife (3)
Date
Today (74)
Last 7 days (279)
Last 30 days (934)
Last 365 days (11799)
2025 (3836)
2024 (12535)
2023 (14284)
2022 (19595)
2021 (20097)
2020 (19063)
2019 (14891)
2018 (11719)
2017 (13892)
2016 (13132)
2015 (15476)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10889)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (56)
Arkansas (3)
Asia (20172)
Australia (2616)
California (1769)
Canada (927)
China (247)
Colorado (71)
Connecticut (70)
Delaware (60)
Europe (39565)
Florida (336)
Georgia (38)
Idaho (9)
Illinois (200)
India (17)
Indiana (136)
Iowa (1)
Japan (93)
Kansas (58)
Kentucky (12)
Louisiana (1)
Maine (2)
Maryland (263)
Massachusetts (1545)
Michigan (30)
Minnesota (95)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (782)
New Mexico (7)
New York (527)
North Carolina (400)
North Dakota (2)
Northern California (729)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (458)
Puerto Rico (8)
Rhode Island (10)
South America (502)
South Carolina (2)
Southern California (743)
Tennessee (34)
Texas (235)
Utah (34)
Virginia (76)
Washington D.C. (31)
Washington State (124)
Wisconsin (17)
266,171 Results for "adare pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist
December 11, 2024
·
6 min read
Press Releases
Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy
October 10, 2024
·
2 min read
Business
Covant Therapeutics Debuts with Boehringer Partnership Targeting ADAR1
Boston-based Covant Therapeutics gained $10 million upfront in a deal with Boehringer Ingelheim to chase after a cancer immunotherapy target, ADAR1.
March 29, 2023
·
3 min read
·
Ana Mulero
Genetown
Covant and Boehringer Ingelheim Collaborate to Develop a Novel ADAR1 Inhibitor for Use in Cancer Patients
Covant Therapeutics, an innovative covalent drug discovery company, has entered into an exclusive research collaboration and worldwide licensing agreement with Boehringer Ingelheim covering Covant’s ADAR1 program.
March 28, 2023
·
2 min read
Genetown
ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing
ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it has successfully defended against two oppositions that were filed against a key patent for its ADAR-mediated RNA editing platform Axiomer®.
March 14, 2023
·
5 min read
Genetown
ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing
ProQR Therapeutics N.V. announced it has further strengthened its leading intellectual property estate with the issuance of a new patent in the United States and that it has successfully defended against an opposition to its IP in Japan.
November 6, 2023
·
5 min read
Business
Adare Pharma Solutions Appoints Ludger Roedder as President, Adare Biome
Adare Pharma Solutions is excited to announce that Ludger Roedder has joined the organization as President of Adare Biome.
April 20, 2021
·
3 min read
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Policy
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
ProQR Therapeutics N.V. today announced it has again successfully defended against opposition filed against a key patent for its ADAR-mediated RNA editing platform Axiomer™.
April 19, 2024
·
5 min read
Mergers & acquisitions
Taiho Pharmaceutical Buys ADC Partner Araris for up to $1.1B Total
Japan-based Taiho Pharmaceutical has worked with Araris Biotech since 2023 developing antibody-drug conjugates for the oncology space.
March 17, 2025
·
2 min read
·
Dan Samorodnitsky
1 of 26,618
Next
